Growth Metrics

Palvella Therapeutics (PVLA) Operating Income Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.69%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -347.04%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 80.62%
7 Evaxion A 62.56 Bn 62.54 Bn - 1.27%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,386.07%
10 Palvella Therapeutics 1.47 Bn 1.21 Bn - -88.73%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -88.73%
Dec 31, 2025 524.60%
Sep 30, 2025 -101.05%
Jun 30, 2025 -218.09%
Mar 31, 2025 -347.47%
Dec 31, 2024 -132.62%
Sep 30, 2024 57.13%
Jun 30, 2024 -240.96%
Mar 31, 2024 88.66%
Sep 30, 2023 2.97%
Jun 30, 2023 116.73%
Mar 31, 2023 -108.01%
Sep 30, 2022 36.00%
Jun 30, 2022 26.44%
Mar 31, 2022 -47.40%
Dec 31, 2021 11.38%
Sep 30, 2021 -46.26%
Jun 30, 2021 -260.06%
Mar 31, 2021 -31.20%
Dec 31, 2020 -833.16%
Sep 30, 2020 -346.09%
Jun 30, 2020 61.94%
Mar 31, 2020 63.91%
Dec 31, 2019 89.48%
Sep 30, 2019 62.66%
Jun 30, 2019 -445.25%
Mar 31, 2019 -31.31%
Dec 31, 2018 -294.94%
Sep 30, 2018 -50.54%
Jun 30, 2018 71.58%
Mar 31, 2018 -1.62%
Dec 31, 2017 201.30%
Sep 30, 2017 16.09%
Jun 30, 2017 -36.16%
Mar 31, 2017 -82.76%
Dec 31, 2016 -149.67%
Sep 30, 2016 -59.23%
Jun 30, 2016 -63.97%
Mar 31, 2016 -18.35%
Sep 30, 2015 -110.74%
Jun 30, 2015 -27.60%
Mar 31, 2015 -451.44%
Sep 30, 2014 -31,852.33%
Jun 30, 2014 -1,010,821.53%